One of the new heights is via Qantas Airlines, which announced through Australian news coverage:
“Qantas passengers will be reminded on flights to get checked for prostate cancer as part of a new campaign to raise awareness of the disease, the airline says.
A specially painted Boeing 737 aircraft displaying the distinctive blue ribbon logo of the Prostate Cancer Foundation of Australia was unveiled at Sydney airport on Thursday.
It comes after Qantas CEO Alan Joyce, 45, recently revealed he underwent surgery for prostate cancer in May after doctors discovered a malignant tumour.”
Australian journalist Melissa Sweet, who tipped me off to this campaign, wrote that Qantas should also give flyers a copy of Australian Simon Chapman’s “Let Sleeping Dogs Lie? What men should know before getting tested for prostate cancer.”
But the new depth in disease awareness campaigns may be the “Hoedown for Hooters” campaign that the Uneasy Pink blog tells readers about.
According to the poster, it will feature a “real men wearing pink bull riding contest.”
The blog raises questions about where the money goes with some of these campaigns – and how much.
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Kathi Kolb
July 30, 2011 at 8:53 pmSigh. Unreal, huh? I apologize to my brothers dealing with prostate cancer if PC ‘awareness’ is starting to take a few pages from the Pink Peril. Maybe you’ll have your own Blue Bombast movement now.
And it’s sooo nice to know that some of the ‘boys’ want to save our hooters, isn’t it??
Bahahah, Gary! My Captcha word is ‘todying’!!!
ellen
July 31, 2011 at 8:08 pmNotice that the poster says “Proceeds to Benefit Breast Cancer”? Really?
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like